Validity of diagnostic codes and estimation of prevalence of diabetic foot ulcers using a large electronic medical record database.


Journal

Diabetes/metabolism research and reviews
ISSN: 1520-7560
Titre abrégé: Diabetes Metab Res Rev
Pays: England
ID NLM: 100883450

Informations de publication

Date de publication:
02 2019
Historique:
received: 20 08 2018
revised: 01 10 2018
accepted: 23 10 2018
pubmed: 1 11 2018
medline: 6 8 2019
entrez: 1 11 2018
Statut: ppublish

Résumé

To assess the validity of the diagnostic codes relating to diabetic foot ulcer (DFU) in the electronic medical records of a large integrated care provider and to assess the prevalence of DFU among its members. Data were obtained from the diabetes registry of Maccabi Healthcare Services (MHS), a 2.1-million-member sick-fund in Israel, which included 125 665 patients in 2015. We randomly selected and reviewed ~400 patient files from each of the following categories during study period: (1) had a diagnostic code of DFU; (2) had a diagnostic code, or clinical condition suggestive of DFU including: leg-ulcer, amputation, DFU in quartiles proximate to 2015 or abnormality reported by nurse; (3) patients at high risk for DFU (age > 35 and one of the following: peripheral artery disease, neuropathy, DFU during 2011-2014, eGFR<30 mL/min/m Relying upon diagnostic codes entered by physicians, the positive predictive value (PPV) was 73.1% (95% CI 67.6-78.2), and the sensitivity was 48.2% (95% CI 45.8-50.7%). The PPV of the diagnostic codes listed by podiatrists were significantly lower, while that of codes listed by nurses was higher but with lower sensitivity. The estimated annual prevalence of DFU in the diabetes registry of MHS was 1.2% (95%CI 1.0-1.5%). Diagnostic codes alone cannot be used reliably to create a DFU registry. Nevertheless, the data collected provide an estimate of the prevalence of DFU among patients included in the MHS diabetes registry.

Identifiants

pubmed: 30378240
doi: 10.1002/dmrr.3094
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

e3094

Informations de copyright

© 2018 John Wiley & Sons, Ltd.

Auteurs

Avivit Cahn (A)

Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Maccabi Healthcare Services, Israel.

Talya Altaras (T)

Maccabi Healthcare Services, Israel.

Tal Agami (T)

Maccabi Healthcare Services, Israel.

Ori Liran (O)

Maccabi Healthcare Services, Israel.

Colette E Touaty (CE)

Maccabi Healthcare Services, Israel.

Michel Drahy (M)

Maccabi Healthcare Services, Israel.

Rena Pollack (R)

Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Maccabi Healthcare Services, Israel.

Itamar Raz (I)

Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Gabriel Chodick (G)

Maccabi Healthcare Services, Maccabi Institute for Research and Innovation, Tel-Aviv, Israel.
School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.

Inbar Zucker (I)

School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
The Israel Center for Disease Control, Ministry of Health, Ramat Gan, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH